Global Gene Therapy for Mucopolysaccharidosis Market Research Report 2023

Report ID: 1988904 | Published Date: Jan 2025 | No. of Page: 65 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gene Therapy for Mucopolysaccharidosis Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Intravenous
        1.2.3 ICV
        1.2.4 Intracerebral
        1.2.5 Intracisternal
    1.3 Market by Application
        1.3.1 Global Gene Therapy for Mucopolysaccharidosis Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Mucopolysaccharidosis I
        1.3.3 Mucopolysaccharidosis II
        1.3.4 Mucopolysaccharidosis III A
        1.3.5 Mucopolysaccharidosis III B
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gene Therapy for Mucopolysaccharidosis Market Perspective (2017-2028)
    2.2 Gene Therapy for Mucopolysaccharidosis Growth Trends by Region
        2.2.1 Gene Therapy for Mucopolysaccharidosis Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gene Therapy for Mucopolysaccharidosis Historic Market Size by Region (2017-2022)
        2.2.3 Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Region (2023-2028)
    2.3 Gene Therapy for Mucopolysaccharidosis Market Dynamics
        2.3.1 Gene Therapy for Mucopolysaccharidosis Industry Trends
        2.3.2 Gene Therapy for Mucopolysaccharidosis Market Drivers
        2.3.3 Gene Therapy for Mucopolysaccharidosis Market Challenges
        2.3.4 Gene Therapy for Mucopolysaccharidosis Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gene Therapy for Mucopolysaccharidosis Players by Revenue
        3.1.1 Global Top Gene Therapy for Mucopolysaccharidosis Players by Revenue (2017-2022)
        3.1.2 Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Players (2017-2022)
    3.2 Global Gene Therapy for Mucopolysaccharidosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gene Therapy for Mucopolysaccharidosis Revenue
    3.4 Global Gene Therapy for Mucopolysaccharidosis Market Concentration Ratio
        3.4.1 Global Gene Therapy for Mucopolysaccharidosis Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Mucopolysaccharidosis Revenue in 2021
    3.5 Gene Therapy for Mucopolysaccharidosis Key Players Head office and Area Served
    3.6 Key Players Gene Therapy for Mucopolysaccharidosis Product Solution and Service
    3.7 Date of Enter into Gene Therapy for Mucopolysaccharidosis Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy for Mucopolysaccharidosis Breakdown Data by Type
    4.1 Global Gene Therapy for Mucopolysaccharidosis Historic Market Size by Type (2017-2022)
    4.2 Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Type (2023-2028)
5 Gene Therapy for Mucopolysaccharidosis Breakdown Data by Application
    5.1 Global Gene Therapy for Mucopolysaccharidosis Historic Market Size by Application (2017-2022)
    5.2 Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gene Therapy for Mucopolysaccharidosis Market Size (2017-2028)
    6.2 North America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2017-2022)
    6.3 North America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Gene Therapy for Mucopolysaccharidosis Market Size (2017-2028)
    7.2 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Country (2017-2022)
    7.3 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size (2017-2028)
    8.2 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Country (2017-2022)
    8.3 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Gene Therapy for Mucopolysaccharidosis Market Size (2017-2028)
    9.2 Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2017-2022)
    9.3 Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size (2017-2028)
    10.2 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Country (2017-2022)
    10.3 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Sangamo Therapeutics
        11.1.1 Sangamo Therapeutics Company Detail
        11.1.2 Sangamo Therapeutics Business Overview
        11.1.3 Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Introduction
        11.1.4 Sangamo Therapeutics Revenue in Gene Therapy for Mucopolysaccharidosis Business (2017-2022)
        11.1.5 Sangamo Therapeutics Recent Development
    11.2 Swedish Orphan Biovitrum
        11.2.1 Swedish Orphan Biovitrum Company Detail
        11.2.2 Swedish Orphan Biovitrum Business Overview
        11.2.3 Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Introduction
        11.2.4 Swedish Orphan Biovitrum Revenue in Gene Therapy for Mucopolysaccharidosis Business (2017-2022)
        11.2.5 Swedish Orphan Biovitrum Recent Development
    11.3 uniQure
        11.3.1 uniQure Company Detail
        11.3.2 uniQure Business Overview
        11.3.3 uniQure Gene Therapy for Mucopolysaccharidosis Introduction
        11.3.4 uniQure Revenue in Gene Therapy for Mucopolysaccharidosis Business (2017-2022)
        11.3.5 uniQure Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Gene Therapy for Mucopolysaccharidosis Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Intravenous
    Table 3. Key Players of ICV
    Table 4. Key Players of Intracerebral
    Table 5. Key Players of Intracisternal
    Table 6. Global Gene Therapy for Mucopolysaccharidosis Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Gene Therapy for Mucopolysaccharidosis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Gene Therapy for Mucopolysaccharidosis Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Gene Therapy for Mucopolysaccharidosis Market Share by Region (2017-2022)
    Table 10. Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Gene Therapy for Mucopolysaccharidosis Market Share by Region (2023-2028)
    Table 12. Gene Therapy for Mucopolysaccharidosis Market Trends
    Table 13. Gene Therapy for Mucopolysaccharidosis Market Drivers
    Table 14. Gene Therapy for Mucopolysaccharidosis Market Challenges
    Table 15. Gene Therapy for Mucopolysaccharidosis Market Restraints
    Table 16. Global Gene Therapy for Mucopolysaccharidosis Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Gene Therapy for Mucopolysaccharidosis Market Share by Players (2017-2022)
    Table 18. Global Top Gene Therapy for Mucopolysaccharidosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Mucopolysaccharidosis as of 2021)
    Table 19. Ranking of Global Top Gene Therapy for Mucopolysaccharidosis Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Gene Therapy for Mucopolysaccharidosis Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Gene Therapy for Mucopolysaccharidosis Product Solution and Service
    Table 23. Date of Enter into Gene Therapy for Mucopolysaccharidosis Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Gene Therapy for Mucopolysaccharidosis Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Type (2017-2022)
    Table 27. Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Type (2023-2028)
    Table 29. Global Gene Therapy for Mucopolysaccharidosis Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Application (2017-2022)
    Table 31. Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Application (2023-2028)
    Table 33. North America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Gene Therapy for Mucopolysaccharidosis Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Gene Therapy for Mucopolysaccharidosis Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Sangamo Therapeutics Company Detail
    Table 44. Sangamo Therapeutics Business Overview
    Table 45. Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Product
    Table 46. Sangamo Therapeutics Revenue in Gene Therapy for Mucopolysaccharidosis Business (2017-2022) & (US$ Million)
    Table 47. Sangamo Therapeutics Recent Development
    Table 48. Swedish Orphan Biovitrum Company Detail
    Table 49. Swedish Orphan Biovitrum Business Overview
    Table 50. Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Product
    Table 51. Swedish Orphan Biovitrum Revenue in Gene Therapy for Mucopolysaccharidosis Business (2017-2022) & (US$ Million)
    Table 52. Swedish Orphan Biovitrum Recent Development
    Table 53. uniQure Company Detail
    Table 54. uniQure Business Overview
    Table 55. uniQure Gene Therapy for Mucopolysaccharidosis Product
    Table 56. uniQure Revenue in Gene Therapy for Mucopolysaccharidosis Business (2017-2022) & (US$ Million)
    Table 57. uniQure Recent Development
    Table 58. Research Programs/Design for This Report
    Table 59. Key Data Information from Secondary Sources
    Table 60. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Therapy for Mucopolysaccharidosis Market Share by Type: 2021 VS 2028
    Figure 2. Intravenous Features
    Figure 3. ICV Features
    Figure 4. Intracerebral Features
    Figure 5. Intracisternal Features
    Figure 6. Global Gene Therapy for Mucopolysaccharidosis Market Share by Application in 2021 & 2028
    Figure 7. Mucopolysaccharidosis I Case Studies
    Figure 8. Mucopolysaccharidosis II Case Studies
    Figure 9. Mucopolysaccharidosis III A Case Studies
    Figure 10. Mucopolysaccharidosis III B Case Studies
    Figure 11. Gene Therapy for Mucopolysaccharidosis Report Years Considered
    Figure 12. Global Gene Therapy for Mucopolysaccharidosis Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Gene Therapy for Mucopolysaccharidosis Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Gene Therapy for Mucopolysaccharidosis Market Share by Region: 2021 VS 2028
    Figure 15. Global Gene Therapy for Mucopolysaccharidosis Market Share by Players in 2021
    Figure 16. Global Top Gene Therapy for Mucopolysaccharidosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Mucopolysaccharidosis as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy for Mucopolysaccharidosis Revenue in 2021
    Figure 18. North America Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Gene Therapy for Mucopolysaccharidosis Market Share by Country (2017-2028)
    Figure 20. United States Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Gene Therapy for Mucopolysaccharidosis Market Share by Country (2017-2028)
    Figure 24. Germany Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Share by Region (2017-2028)
    Figure 32. China Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Gene Therapy for Mucopolysaccharidosis Market Share by Country (2017-2028)
    Figure 40. Mexico Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Share by Country (2017-2028)
    Figure 44. Turkey Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Sangamo Therapeutics Revenue Growth Rate in Gene Therapy for Mucopolysaccharidosis Business (2017-2022)
    Figure 47. Swedish Orphan Biovitrum Revenue Growth Rate in Gene Therapy for Mucopolysaccharidosis Business (2017-2022)
    Figure 48. uniQure Revenue Growth Rate in Gene Therapy for Mucopolysaccharidosis Business (2017-2022)
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sangamo Therapeutics
Swedish Orphan Biovitrum
uniQure
Frequently Asked Questions
Gene Therapy for Mucopolysaccharidosis report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gene Therapy for Mucopolysaccharidosis report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gene Therapy for Mucopolysaccharidosis report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports